| Literature DB >> 31749920 |
Abolfazl Nikpour1, Alireza Khalilian2, Iradj Maleki3, Hossein Mohsenipouya3, Jamshid Yazdani Charati4.
Abstract
AIM: Survey of the survival levels of gastric cancer and its effective causes.Entities:
Keywords: Gastric cancer; Kaplan Meier estimate; Survival analysis
Year: 2019 PMID: 31749920 PMCID: PMC6820842
Source DB: PubMed Journal: Gastroenterol Hepatol Bed Bench ISSN: 2008-2258
Demographic and pathologic characteristics of studied patients
| Variable | N of death (%) | Total patients (%) | |
|---|---|---|---|
| Sex | Male | 224(72.5) | 381(70) |
| Female | 85(27.5) | 163(30) | |
| City | Urban | 170(61.2) | 288(60.8) |
| Rural | 108(38.8) | 186(29.2) | |
| Job | Farmer | 160(48.6) | 222(39.3) |
| Non farmer | 169(51.4) | 343(60.7) | |
| Family history | Negative | 114(56.2) | 149(58.2) |
| First degree GI cancer | 50(24.6) | 63(24.6) | |
| Second degree GI cancer | 4(2) | 5(2) | |
| First degree non GI cancer | 33(16.3) | 36(14.1) | |
| Second degree non GI cancer | 2(1) | 3(1.2) | |
| Age | < 45 year | 20(6.2) | 50(9) |
| 45-65 year | 114(35.3) | 188(42.8) | |
| ≥ 65 year | 189(58.5) | 318(57.2) | |
| Stage | 1 | 8(3.3) | 27(6.8) |
| 2 | 27(11.3) | 55(13.9) | |
| 3 | 63(26.4) | 98(24.7) | |
| 4 | 141(59) | 217(54.7) | |
| Site.tumor | Cardia | 66(39.3) | 122(40.1) |
| Body | 21(12.5) | 31(10.2) | |
| Antrum | 48(28.6) | 98(32.2) | |
| Lesser curvature | 22(13.1) | 36(11.8) | |
| Greater curvature | 4(2.4) | 6(2) | |
| Fundus | 7(4.2) | 11(3.6) | |
| Type of tumor | Adenocarcinoma | 211(91.7) | 359(90.2) |
| SCC+GIST+Adeno Signet Ring | 19(8.3) | 39(9.8) | |
| Metastasissite at presentation | Liver | 41(17.2) | 72(17.6) |
| Bone | 25(10.5) | 41(10) | |
| Liver+ Lung | 3(1.3) | 3(0.7) | |
| Para Aortic | 6(2.5) | 12(2.9) | |
| Lung | 4(1.7) | 5(1.2) | |
| Ascitis | 8(3.3) | 14(3.4) | |
| Paraourticlap+Liver | 2(0.8) | 5(1.2) | |
| Other | 6(2.5) | 9(2.2) | |
| No | 144(60.3) | 247(60.5) | |
| Undergo Surgery before (Adjuvant Chemotherapy) | Yes | 166(60.6) | 294(63.8) |
| No | 108(39.4) | 167(36.2) | |
| Undergo Surgery after (Neoadjuvant Chemotherapy) | Yes | 13(72.2) | 32(78) |
| No | 5(27.8) | 9(22) | |
| Chemotherapy Receive or not | Yes | 241(74.2) | 425(76.4) |
| No | 84(25.8) | 131(23.6) | |
| Cause of DC of chemotherapy | Not indicated | 5(6.3) | 15(12.1) |
| Low performance | 6(7.5) | 6(4.8) | |
| Refuse | 5(6.3) | 6(4.8) | |
| Consult | 64(80) | 97(78.2) | |
| RT | Yes | 81(27.5) | 138(28.1) |
| No | 214(72.5) | 353(71.9) | |
Figure 1Survival diagram based on the disease stage
Factors affected on survival time of gastric cancer patients based on using COX regression
| Variable | p-value | Rank | j/m)*0.05) | RH0 | |
|---|---|---|---|---|---|
| Family history | 0.702 | 21 |
| 0.042 | ▀ |
| Sex | 0.723 | 22 |
| 0.044 | ▀ |
| Age | 0.191 | 12 |
| 0.024 | ▀ |
| Job | 0.232 | 13 |
| 0.026 | ▀ |
| City | 0.992 | 25 |
| 0.05 | ▀ |
| Stage | <0.001 | 1 |
| 0.002 | |
| site.of.tumor | 0.741 | 23 |
| 0.046 | ▀ |
| type.of.tumor | 0.259 | 14 |
| 0.028 | ▀ |
| metastasis.site.at.presentation | 0.044 | 8 |
| 0.016 | ▀ |
| OP.BEFOR | <0.001 | 2 |
| 0.004 | |
| OP.AFTER | 0.0613 | 9 |
| 0.018 | ▀ |
| site.of.relaps | 0.83 | 10 |
| 0.02 | ▀ |
| time.of.relaps | 0.038 | 7 |
| 0.014 | ▀ |
| Progression | 0.636 | 20 |
| 0.040 | ▀ |
| time.of.prog | 0.545 | 18 |
| 0.036 | ▀ |
| type.of.regimen | 0.019 | 5 |
| 0.010 | ▀ |
| howmany.course | 0.548 | 19 |
| 0.038 | ▀ |
| CT | 0.847 | 24 |
| 0.048 | ▀ |
| Diarrhea | 0.402 | 16 |
| 0.032 | ▀ |
| Neuropathy | 0.028 | 6 |
| 0.012 | ▀ |
| Neutropenia | 0.102 | 11 |
| 0.022 | ▀ |
| cause.CT.dc | 0.503 | 17 |
| 0.034 | ▀ |
| RT | 0.005 | 3 |
| 0.006 | |
| TreatCompl | 0.321 | 15 |
| 0.03 | ▀ |
| reson.of.chemo.D.C | 0.019 | 4 |
| 0.008 | ▀ |